DIRS.INFO The most relevant business & tech news

☆ FDA rejection of MDMA-assisted therapy rattles advocates but doesn’t spell end of psychedelics in medicine, experts say
▼ + stars: | 2024-08-13 | by ( Deidre Mcphillips | Carma Hassan | ) edition.cnn.com time to read: +11 min

The initial application from Lykos presented positive data from two late-stage clinical trials that used MDMA in combination with talk therapy to treat PTSD. The advisers said it was also difficult to parse how much the accompanying talk therapy — an area that the FDA does not regulate — contributed to outcomes. Advocates for the treatment, including some veterans groups, said they were “incredibly disappointed” by the FDA decision. Dozens of clinical trials involving psychedelics are in various stages, and additional scrutiny can help strengthen the findings and build confidence. Psychopharmacology did not allow the study authors to publish a correction with data that excluded findings from one study site, said Allison Feduccia, an author in all three retracted studies.

Persons: Lykos, —, ” Martin Steele, Brett Waters, ”, Rachel Yehuda, “, ‘, Michael Bogenschutz, Yehuda, It’s, Lori Bruce, Psychopharmacology, caressed, “ it’s, Amy Emerson, ” Lykos, Allison Feduccia, Dr, Sanjay Gupta, Brian Barnett, ” Bruce, Nadia Kounang Organizations: CNN, Food and Drug Administration, Lykos Therapeutics, FDA, Veteran Mental Health Leadership Coalition, Hope, Center, Psychedelic Psychotherapy, Mount, Icahn, of Medicine, NYU Langone Center, Psychedelic Medicine, Oxford, NUS, Neuroethics, Interdisciplinary Center, Bioethics, Yale University, ”, Multidisciplinary Association for Psychedelic Studies, Health Canada, Institutional, Board, CNN Health, Cleveland Clinic Locations: Canada, “

☆ This is a healthy brain on psilocybin
▼ + stars: | 2024-07-17 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +8 min

It wasn’t until his brain morphed into a computer, however, that he knew for sure he was on a psychedelic trip. “We found that psilocybin desynchronizes the brain,” said co-senior author Ginger Nichols of the study published Wednesday in the journal Nature. “When psilocybin is on board, the brain is disconnecting from its typical pathways and reconnecting to different parts of the brain,” said Nichols, an associate professor of psychiatry at Washington University School of Medicine in St. Louis. “Science doesn’t fully understand the brain yet, but I felt as if I suddenly knew exactly how the brain works. Sara Moser/Washington University School of MedicineA window for changeScans showed that in the days after the psilocybin trip, most brain networks returned to normal.

Persons: Dr, Nico Dosenbach wasn’t, he’d, it’s, ”, Dosenbach, St . Louis, “, ” Dosenbach, Ginger Nichols, Nichols, ” Nichols, psychotherapists, Petros Petridis, ” Petridis, Sara Moser Organizations: CNN, Washington University School of Medicine, US Food and Drug Administration, NYU Langone Center, Psychedelic Medicine, Washington University School of Locations: “, St ., Oregon, New York City, reconnection

☆ Psychedelic therapies are on the horizon. Who will administer them?
▼ + stars: | 2022-12-26 | by ( Danica Jefferies | Danica Jefferies Is An Intern With The Data Graphics Team For Nbc News Digital. | ) www.nbcnews.com time to read: +11 min

Psychedelic therapy is nowhere near as simple as filling a prescription and taking a pill at home. A clinical psychologist, she founded and now leads the first accredited psychedelic therapy training program in the U.S. at the California Institute of Integral Studies. The psychedelic therapy program entails 150 hours of instruction and several in-person training sessions. So why the growing interest in using psychedelic drugs for mental health? Treatment with psychedelic drugs is not as simple as giving the patient a pill to take at home, and it’s not for everybody.

Bogenschutz and his team specifically set out to test whether or not psilocybin, in addition to sessions of therapy, could cut cravings and help people with alcohol use disorder stay sober. Earlier research from institutions around the world has indicated that psilocybin has the potential to treat a variety of addiction disorders, including alcohol use disorder, opioid use disorder and addiction to smoking. Jon KostasWhen he began the psilocybin trial at age 25, he was consuming almost 23 drinks in a single bender. At the beginning of the first dose sessions, participants were given eye masks and headphones that played classical music. Bogenschutz said the rule of thumb with alcohol addiction treatment is that about one-third of patients who seek treatment will get better.

☆ STUDIU: Vaccinurile Pfizer şi Moderna, eficiente împotriva variantei de coronavirus descoperită în India
▼ + stars: | 2021-05-18 | by ( Publika.Md - Aici Sunt Știrile | ) www.publika.md time to read: +2 min

Vaccinurile Pfizer şi Moderna anti-Covid ar trebui să rămână extrem de eficiente împotriva a două variante identificate pentru prima dată în India, potrivit noilor cercetări efectuate de oamenii de ştiinţă din SUA. Studiul de laborator a fost realizat de Şcoala de Medicină NYU Grossman şi NYU Langone Center şi este considerat preliminar, deoarece nu a fost încă publicat într-un jurnal, înainte de a fi evaluat de colegi, scrie Mediafax. Acest amestec a fost apoi pus în contact cu celulele cultivate în laborator, pentru a observa câte ar fi infectate. Pentru varianta B.1.618, reducerea a fost de aproximativ trei ori. Sunt destui care îşi fac treaba, încât credem că vaccinurile vor rămâne extrem de eficiente," a adăugat Nathaniel Landau.

Persons: Grossman, Nathaniel, Ned Landau, Nathaniel Landau Organizations: NYU Langone, Mediafax Locations: India, SUA, NYU, NYU Langone Center, Statele Unite, pseudovirus

Search resuls for: "NYU Langone Center"

5 mentions found